MedicalArt: what changed
What changed
MedicalArt
NACE 85.592, Vocational training
filed annual accounts (NBB)
Net result for the year
€125,652
2024 · €128,391-€2,739
Equity
€23,298
2024 · €347,430-€324,132
Cash
€240,062
2024 · €150,225+€89,837
Balance sheet total
€478,226
2024 · €390,686+€87,539
Largest movements
Assets
- Cash +€89,837
up €89,837 (+59.8%), from €150,225 to €240,062
mainly Other debts (+€380,962) and Net result for the year (+€125,652)
- Receivables within one year -€5,865
down €5,865 (-8.8%), from €66,565 to €60,700
of which Trade receivables: -€7,648
Equity and liabilities
- Other debts +€380,962
up €380,962 (+28,118%), from €1,355 to €382,316
- Profit (loss) carried forward -€324,132
down €324,132 (-94.1%), from €344,430 to €20,298
- Tax, wage and social debts +€30,564
up €30,564 (+73.8%), from €41,404 to €71,968
Income statement
- Gross operating margin -€3,855
down €3,855 (-2.3%), from €168,744 to €164,889
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€128,391
Gross operating margin
-€3,855
Depreciation
-€589
Other operating charges
+€127
Financial income
+€637
Financial charges
-€54
Taxes
+€995
Result 2025
€125,652
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€547,224
Investment
-€7,603
Financing
-€449,784
Cash 2024
€150,225
From operations (derived)
+€547,224
Net result for the year
+€125,652
Depreciation
+€4,824
Receivables within one year
+€5,865
Smaller working-capital items
-€642
Tax, wage and social debts
+€30,564
Other debts
+€380,962
Investment (derived)
-€7,603
Investment in fixed assets (net)
-€4,480
Current investments
-€3,122
Financing
-€449,784
Contributions, distributions and other
-€449,784
Cash 2025
€240,062
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €390,686 | €478,226 | +€87,539 | +22.4% |
| Fixed assets | 21/28 | €11,855 | €11,511 | -€344 | -2.9% |
| Tangible fixed assets | 22/27 | €11,855 | €11,511 | -€344 | -2.9% |
| Plant, machinery and equipment | 23 | €4,525 | €3,471 | -€1,054 | -23.3% |
| Furniture and vehicles | 24 | €7,329 | €8,040 | +€711 | +9.7% |
| Current assets | 29/58 | €378,832 | €466,715 | +€87,883 | +23.2% |
| Amounts receivable within one year | 40/41 | €66,565 | €60,700 | -€5,865 | -8.8% |
| Trade receivables | 40 | €66,565 | €58,917 | -€7,648 | -11.5% |
| Other amounts receivable | 41 | - | €1,783 | +€1,783 | |
| Current investments | 50/53 | €160,180 | €163,303 | +€3,122 | +1.9% |
| Cash at bank and in hand | 54/58 | €150,225 | €240,062 | +€89,837 | +59.8% |
| Deferred charges and accrued income | 490/1 | €1,862 | €2,650 | +€788 | +42.3% |
| Total equity and liabilities | 10/49 | €390,686 | €478,226 | +€87,539 | +22.4% |
| Equity | 10/15 | €347,430 | €23,298 | -€324,132 | -93.3% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €344,430 | €20,298 | -€324,132 | -94.1% |
| Amounts payable | 17/49 | €43,257 | €454,928 | +€411,671 | +952% |
| Amounts payable within one year | 42/48 | €43,257 | €454,928 | +€411,671 | +952% |
| Trade debts | 44 | €498 | €644 | +€146 | +29.3% |
| Suppliers | 440/4 | €498 | €644 | +€146 | +29.3% |
| Taxes, remuneration and social security | 45 | €41,404 | €71,968 | +€30,564 | +73.8% |
| Taxes | 450/3 | €41,404 | €71,968 | +€30,564 | +73.8% |
| Other amounts payable | 47/48 | €1,355 | €382,316 | +€380,962 | +28,118% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,235 | €4,824 | +€589 | +13.9% |
| Other operating charges | 640/8 | €694 | €567 | -€127 | -18.3% |
| Gross operating margin | 9900 | €168,744 | €164,889 | -€3,855 | -2.3% |
| Operating profit (loss) | 9901 | €163,815 | €159,498 | -€4,317 | -2.6% |
| Financial income | 75/76B | €2,120 | €2,757 | +€637 | +30.1% |
| Recurring financial income | 75 | €2,120 | €2,757 | +€637 | +30.1% |
| Financial charges | 65/66B | €124 | €178 | +€54 | +43.5% |
| Recurring financial charges | 65 | €124 | €178 | +€54 | +43.5% |
| Profit (loss) for the period before taxes | 9903 | €165,811 | €162,077 | -€3,734 | -2.3% |
| Income taxes | 67/77 | €37,420 | €36,425 | -€995 | -2.7% |
| Profit (loss) for the period | 9904 | €128,391 | €125,652 | -€2,739 | -2.1% |
| Profit (loss) for the period to be appropriated | 9905 | €128,391 | €125,652 | -€2,739 | -2.1% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 6 November 2026 via checked.be.